| Study on the Population Pharmacokinetics of Levetiracetam in Epileptic Patients With Diabetic Kidney Disease (NCT05330390) | The Second Hospital of Shandong University | 2022-04-04 |
| The Expression of circANKRD36 as a New Biomarker of Diabetic Nephropathy (NCT05061459) | Assiut University | 2021-10-01 |
| Study on the Efficacy and Safety of a Novel Tripterygium Wilfordii Preparation in Reducing Proteinuria in Patients With Diabetic Nephropathy (NCT04981613) | First Affiliated Hospital Xi'an Jiaotong University | 2021-07-28 |
| Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC73077 in Healthy Subjects (NCT05492630) | Sunshine Lake Pharma Co., Ltd. | 2021-05-24 |
| Raman Spectroscopy Diagnosis of Kidney Diseases (NCT06760845) | Zunsong Wang | 2021-02-01 |
| Enhanced Recovery After Surgery for SPK Transplantation Recipients (NCT06095544) | Second Affiliated Hospital of Guangzhou Medical University | 2021-01-01 |
| Renal Oxygenation, Oxygen Consumption and Hemodynamic Kinetics in Type 2 DIabetes: an Ertugliflozin Study. (NCT04027530) | Amsterdam UMC, location VUmc | 2020-12-10 |
| Clinical Research of UC-MSCs in the Treatment of Diabetic Nephropathy (NCT04562025) | Renmin Hospital of Wuhan University | 2020-09-25 |
| Pain Neuroscience Education in Diabetic Neuropathy (NCT04721847) | Riphah International University | 2020-08-13 |
| Expression Analysis of Urinary Exosome in Type 2 Diabetic Kidney Disease and Evaluation of Its Clinical Diagnostic Value (NCT06123871) | Yipeng Liu | 2020-06-01 |
| Expression Analysis of Urinary Exosome in Type 2 Diabetic Nephropathy and Evaluation of Its Clinical Diagnostic Value (NCT06097351) | Yipeng Liu | 2020-06-01 |
| Umbilical Cord Mesenchymal Stem Cells Therapy for Diabetic Nephropathy (NCT04125329) | Yan'an Affiliated Hospital of Kunming Medical University | 2020-04-01 |
| Effects of SGLT2 Inhibition Treatment on Different Levels of Albuminuria in Patients With Type 2 Diabetes (NCT04127084) | Zhongshan Hospital Xiamen University | 2019-10-15 |
| Assessment of Urinary Uromodulin and the Corresponding Gene Expression as a Biomarker of Diabetic Nephropathy (NCT05695573) | Tanta University | 2019-07-05 |
| Effects of Multidisciplinary Intensive Targeted Care in Improving Diabetes Outcomes: a Pilot Study in Singapore (NCT03413215) | Changi General Hospital | 2019-03-01 |
| Renal Resisitive Index as an Indicator of the Progression of Diabetic Nephropathy (NCT03658317) | Assiut University | 2018-09-01 |
| Efficacy and Safety of Canagliflozin (TA-7284) in Patients With Diabetic Nephropathy (NCT03436693) | Tanabe Pharma Corporation | 2018-02-15 |
| Telmisartan Promotes the Differentiation of Monocytes Into Macrophages M2 in Diabetic Nephropathy? (NCT02768948) | Centre Hospitalier Universitaire de Nice | 2017-05-05 |
| Effect of Urinary Alkalinization on Urine Uric Acid Precipitation and Crystallization in Adults With Type 1 Diabetes (NCT02502071) | University of Colorado, Denver | 2017-01-01 |
| Effect of Pirfenidone on Glomerular Filtration Rate and Albuminuria in Patients With Diabetic Nephropathy (NCT02689778) | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 2016-03-01 |
| Resveratrol's Effects in Diabetic Nephropathy (NCT02704494) | Shiraz University of Medical Sciences | 2016-03-01 |
| An Extended Treatment Study of MT-3995 in Patients With Diabetic Nephropathy (NCT02676401) | Tanabe Pharma Corporation | 2016-02-01 |
| Effect of Gastric Bypass Surgery on Diabetes Status and Microvascular Complications in Obese Type 2 Diabetic Patients (NCT02625649) | University of Aarhus | 2016-01-01 |
| Microalbuminuria as a Cardiovascular Risk Factor (PRECISED Substudy) (NCT02409511) | Hospital Universitari Vall d'Hebron Research Institute | 2016-01-01 |
| Lipo-prostaglandin E1 Improves Renal Hypoxia Evaluated by BOLD-MRI in Patients With Diabetic Nephropathy (NCT02628106) | West China Hospital | 2015-12-01 |
| Effects of Dapagliflozin Treatment on Urinary Proteomic Patterns in Patients With Type 2 Diabetes (NCT02914691) | Peter Rossing | 2015-08-01 |
| Role of Carnosine as an Adjuvant Therapy for Diabetic Nephropathy in Pediatrics With Type 1 Diabetes (NCT02928250) | Ain Shams University | 2015-08-01 |
| Efficacy and Safety of MT-3995 in Patients With Diabetic Nephropathy (NCT02517320) | Tanabe Pharma Corporation | 2015-07-01 |
| Efficacy and Safety of Weekly Subcutaneous MLN1202 in Improving Diabetic Nephropathy in Participants With Macroalbuminuria (NCT02410499) | Takeda | 2015-05-20 |
| A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Type 2 Diabetic Subjects With Microalbuminuria (NCT02345057) | Daiichi Sankyo | 2015-01-01 |
| Mechanisms of Diabetic Nephropathy in Ecuador (NCT02237352) | Universidad Estatal de Milagro | 2014-09-15 |
| The Evaluation of Effect of Sanyinjiao (SP6) Acupressure on Early Diabetic Nephropathy (NCT02501772) | Mackay Memorial Hospital | 2014-09-01 |
| Microalbuminuria and Allopurinol in Type 1 Diabetes (NCT02829177) | Peter Rossing | 2014-09-01 |
| Effect of LIXIsenatide on the Renal System (NCT02276196) | Amsterdam UMC, location VUmc | 2014-09-01 |
| The Significance of Urine UbA52 In the Diagnosis of Diabetic Nephropathy (NCT02204280) | Hebei Medical University Third Hospital | 2014-08-01 |
| Safety, Tolerability and Pharmacokinetic Study of MT-3995 at a Low Dose in Subjects With Diabetic Nephropathy (NCT02205372) | Tanabe Pharma Corporation | 2014-07-01 |
| Pyridorin in Diabetic Nephropathy (NCT02156843) | NephroGenex, Inc. | 2014-06-01 |
| The Differential Effects of Diabetes Therapy on Inflammation (NCT02150707) | University College Dublin | 2014-05-01 |
| Effect of Low GI/ Glycemic Load (GL) Diet in Diabetic Nephropathy Patients (NCT02384902) | Isfahan University of Medical Sciences | 2014-05-01 |
| A Study to Learn How Finerenone (BAY94-8862) Moves Into, Through and Out of the Body, How it Affects the Body, and How Safe it is in Adult Participants With Different Degrees of Reduced Liver Function and in Healthy Participants With Similar Age, Weight and Gender Distribution (NCT04881994) | Bayer | 2014-03-25 |
| Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria (NCT02040441) | Peter Rossing | 2014-03-01 |
| Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy (NCT02065791) | Janssen Research & Development, LLC | 2014-02-17 |
| SWIDINEP a Swiss Diabetic Nephropathy Cohort (NCT03407989) | Centre Hospitalier Universitaire Vaudois | 2014-01-01 |
| Ayurvedic Management of Chronic Kidney Disease (NCT02477163) | J.S. Ayurveda College | 2014-01-01 |
| Low-dose Colchicine in Patients With Type 2 Diabetes Mellitus and Microalbuminuria (NCT02035891) | Chongqing Medical University | 2013-12-01 |
| Effect of Green Tea (Epigallocatechin Gallate) on Albuminuria in Patients With Diabetic Nephropathy. (NCT01923597) | University of Campinas, Brazil | 2013-11-01 |
| To Determine the Efficacy and Safety of DW1029M on Microalbuminuria in Patients With Diabetic Nephropathy (NCT01935167) | Dong Wha Pharmaceutical Co. Ltd. | 2013-10-01 |
| Safety, Tolerability and Pharmacokinetic Study of MT-3995 in Subjects With Diabetic Nephropathy (NCT01889277) | Tanabe Pharma Corporation | 2013-07-01 |
| Safety and Efficacy of Mesenchymal Precursor Cells in Diabetic Nephropathy (NCT01843387) | Mesoblast, Ltd. | 2013-07-01 |
| Study of LY3016859 in Participants With Diabetic Nephropathy (NCT01774981) | Eli Lilly and Company | 2013-03-01 |
| Beraprost Sodium and Arterial Stiffness in Patients With Type 2 Diabetic Nephropathy (NCT01796418) | Seoul National University Hospital | 2013-03-01 |
| Effect of Sarpogrelate On the Nephropathy in Type 2 Diabetes (SONATA Study) (NCT01869881) | Yuhan Corporation | 2013-02-01 |
| Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID) (NCT01802034) | The Rogosin Institute | 2013-02-01 |
| A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy (NCT01712061) | Pfizer | 2012-12-01 |
| Effect of Integrated CKD Care Program in Early Diabetic Nephropathy in Primary Health Care Setting. (NCT02194790) | Bhumirajanagarindra Kidney Institute, Thailand | 2012-12-01 |
| A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria and Moderately Decreased GFR (NCT01756716) | Tanabe Pharma Corporation | 2012-12-01 |
| Prevention of Renal Complications of Diabetes With Thiamine (NCT01725412) | University of Saskatchewan | 2012-11-01 |
| A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria (NCT01756703) | Tanabe Pharma Corporation | 2012-11-01 |
| Efficacy and Safety Study of Probucol in Patients With Diabetic Nephropathy (NCT01726816) | Korea Otsuka Pharmaceutical Co., Ltd. | 2012-10-01 |
| Clinical Trial Technology Development for the Validation of Surrogate Prognostic Markers in Patients With Diabetic Nephropathy (NCT01673204) | Seoul National University Hospital | 2012-10-01 |
| Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients (NCT01601236) | Mallinckrodt | 2012-05-01 |
| Mycophenolate Mofetil, Carnitine and PDE5 Inhibitor, Three Potential Treatments for Resistant Proteinuria Slowing Diabetic Nephropathy Deterioration (NCT01566006) | The Nazareth Hospital, Israel | 2012-04-01 |
| Renal Denervation in Diabetic Nephropathy (NCT01588795) | Assistance Publique - Hôpitaux de Paris | 2012-04-01 |
| The Effects of Sevelamer Carbonate on Diabetic Nephropathy (NCT01493050) | Gary Striker | 2012-02-01 |
| Vitamin D Supplementation in Diabetic Nephropathy (NCT01476501) | University of Alberta | 2011-10-01 |
| A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Diabetic Nephropathy (NCT01447147) | Amgen | 2011-10-01 |
| Matrix Metalloproteinases in Atherosclerosis of Chronic Kidney Disease (NCT01458158) | Aristotle University Of Thessaloniki | 2011-10-01 |
| A Study to Evaluate the Effect of CCX140-B on Urinary Albumin Excretion in Subjects With Type 2 Diabetes and Albuminuria (NCT01440257) | Amgen | 2011-09-01 |
| Reducing Residual Albuminuria in Subjects With Diabetes and Nephropathy With Atrasentan (NCT01424319) | AbbVie (prior sponsor, Abbott) | 2011-08-01 |
| A Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in Type 2 Diabetic Subjects With Nephropathy (NCT01399580) | AbbVie (prior sponsor, Abbott) | 2011-08-01 |
| Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled Dose of a Renin Angiotensin System (RAS) Inhibitor (NCT01356849) | AbbVie (prior sponsor, Abbott) | 2011-04-01 |
| Effect of Sulodexide on Albuminuria in Chinese Type 2 Diabetic Patients (NCT01316068) | Sun Yat-sen University | 2011-03-01 |
| N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy (NCT01265563) | VA Office of Research and Development | 2011-01-01 |
| Impact of c242T Polymorphism of p22phox in Diabetic type1 Nephropathy (NCT01371955) | University Hospital, Grenoble | 2011-01-01 |
| Molecular and Clinical Profile of Diabetes Mellitus and Its Complications (NCT01105858) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2010-11-16 |
| Evaluating the Renoprotective Effect of Milk Thistle Extract on Patients With Type II Diabetic Nephropathy (NCT01003236) | Shiraz University of Medical Sciences | 2010-10-01 |
| An Investigation on the Effect of Candesartan on Early Diabetic Nephropathy (NCT01273675) | National Taiwan University Hospital | 2010-09-01 |
| Effects of PH3 in Diabetic Nephropathy (NCT01068041) | PhytoHealth Corporation | 2010-08-01 |
| A Study in Participants With Diabetic Kidney Disease (NCT01113801) | Eli Lilly and Company | 2010-07-01 |
| The Effect of Green Tea or Cocoa Extracts in Endothelial Dysfunction in Patients With Diabetes Mellitus (NCT01130727) | University of Campinas, Brazil | 2010-05-01 |
| Effect of a Vitamin D Analogue vs Placebo on p-NT-proBNP in Patients With Type 1 DM and Diabetic Nephropathy (NCT01331317) | Peter Rossing | 2010-04-01 |
| Colchicine for Diabetic Nephropathy (NCT01005121) | Prof.Avi Livneh | 2009-12-01 |
| Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease (NCT01129557) | Columbia University | 2009-09-01 |
| Flavonoids in the Treatment of Endothelial Dysfunction in Children With Diabetes (NCT01307917) | Texas Tech University Health Sciences Center | 2009-07-01 |
| Effect of Sevelamer Carbonate on Oxidative Stress in Patients With Diabetic Nephropathy (NCT00967629) | Icahn School of Medicine at Mount Sinai | 2009-06-01 |
| A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors (NCT00920764) | AbbVie (prior sponsor, Abbott) | 2009-06-01 |
| Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN) (NCT01028287) | Southeast Renal Research Institute | 2009-05-01 |
| Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease (NCT00811889) | Biogen | 2009-04-30 |
| Aldosterone in Diabetic Nephropathy (NCT00870402) | Universidad de los Andes, Chile | 2009-03-01 |
| Estimation of Glomerular Filtration Rate (GFR) in Patients With Type 2 Diabetes Mellitus. (NCT01215994) | AHEPA University Hospital | 2009-03-01 |
| Minocycline and Proteinuria in Diabetic Nephropathy (NCT01779089) | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | 2009-02-01 |
| Study of FibroGen (FG)-3019 in Subjects With Type 2 Diabetes Mellitus and Kidney Disease on ACEi and/or ARB Therapy (NCT00913393) | Kyntra Bio | 2009-02-01 |
| To Assess the Accuracy of the eZscan Study in the Screening for Diabetic Nephropathy (NCT01163591) | Chinese University of Hong Kong | 2009-01-01 |
| Safety and Efficacy Study of Pyridorin in Patients With Nephropathy Due to Type 2 Diabetes (NCT00734253) | NephroGenex, Inc. | 2008-08-01 |
| Phase IIa Trial to Determine the Effects of Bardoxolone Methyl on Renal Function in Patients With Diabetic Nephropathy (NCT00664027) | Biogen | 2008-04-30 |
| Phase 1 Study of FG-3019 in Subjects With Type 1 or Type 2 Diabetes Mellitus and Diabetic Nephropathy (NCT00754143) | Kyntra Bio | 2008-03-01 |
| Effect of Turmeric on Diabetic Nephropathy (NCT01015937) | Shaheed Faghihi Hospital | 2008-03-01 |
| FGF-23 and Endothelial Dysfunction in Diabetic Proteinuric Patients (NCT01703234) | Gulhane School of Medicine | 2008-01-01 |
| Effect of Renin Angiotensin System Blockade on the Fas Antigen (CD95) and Asymmetric Dimethylarginine (ADMA) Levels in Type-2 Diabetic Patients With Proteinuria (NCT00893425) | Gulhane School of Medicine | 2008-01-01 |
| Benfotiamine in Diabetic Nephropathy (NCT00565318) | University Medical Center Groningen | 2007-12-01 |